Sternberg CN - Search Results

1

Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel.

Fitzpatrick JM, Bellmunt J, Fizazi K, Heidenreich A, Sternberg CN, Tombal B, Alcaraz A, Bahl A, Bracarda S, Di Lorenzo G, Efstathiou E, Finn SP, Fosså S, Gillessen S, Kellokumpu-Lehtinen PL, Lecouvet FE, Oudard S, de Reijke TM, Robson CN, De Santis M, Seruga B, de Wit R. Fitzpatrick JM, et al. Among authors: sternberg cn. Eur J Cancer. 2014 Jun;50(9):1617-27. doi: 10.1016/j.ejca.2014.03.010. Epub 2014 Apr 3. Eur J Cancer. 2014. PMID: 24703899 Free article.

2

Transurethral resection of the prostate and metastatic prostate cancer.

Pansadoro V, Sternberg CN, DePaula F, Florio A, Giannarelli D, Arcangeli G. Pansadoro V, et al. Among authors: sternberg cn. Cancer. 1991 Nov 1;68(9):1895-8. doi: 10.1002/1097-0142(19911101)68:9<1895::aid-cncr2820680908>3.0.co;2-b. Cancer. 1991. PMID: 1913540

3

The application of hematopoietic growth factors in advanced transitional cell carcinoma of the urinary tract.

de Mulder PH, Sternberg CN, van Oosterom AT, Fossa SD. de Mulder PH, et al. Among authors: sternberg cn. Semin Oncol. 1994 Feb;21(1 Suppl 1):65-9. Semin Oncol. 1994. PMID: 7512278 Review. No abstract available.

4

Escalated M-VAC chemotherapy and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with advanced urothelial tract tumors.

Sternberg CN, de Mulder PH, van Oosterom AT, Fossa SD, Giannarelli D, Soedirman JR. Sternberg CN, et al. Ann Oncol. 1993 May;4(5):403-7. doi: 10.1093/oxfordjournals.annonc.a058520. Ann Oncol. 1993. PMID: 8353075 Free article.

5

Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder.

Sternberg CN, Arena MG, Calabresi F, De Carli P, Platania A, Zeuli M, Giannarelli D, Cancrini A, Pansadoro V. Sternberg CN, et al. Cancer. 1993 Sep 15;72(6):1975-82. doi: 10.1002/1097-0142(19930915)72:6<1975::aid-cncr2820720631>3.0.co;2-i. Cancer. 1993. PMID: 8364877 Clinical Trial.

6

Lobaplatin in advanced urothelial tract tumors. The Genitourinary Group of the European Organization for Research and Treatment of Cancer (EORTC).

Sternberg CN, de Mulder P, Fossa S, Kaye S, Roberts T, Pawinsky A, Daamen S. Sternberg CN, et al. Ann Oncol. 1997 Jul;8(7):695-6. doi: 10.1023/a:1008269432176. Ann Oncol. 1997. PMID: 9296225 Free article. Clinical Trial. No abstract available.

7

Current perspectives in muscle invasive bladder cancer.

Sternberg CN. Sternberg CN. Eur J Cancer. 2002 Mar;38(4):460-7. doi: 10.1016/s0959-8049(01)00393-8. Eur J Cancer. 2002. PMID: 11872337 Review.

8

Systemic treatment and new developments in advanced prostate cancer.

Sternberg CN. Sternberg CN. Eur J Cancer. 2001 Oct;37 Suppl 7:S147-57. doi: 10.1016/s0959-8049(01)80016-2. Eur J Cancer. 2001. PMID: 11887986 Review. No abstract available.

9

Treatment options in hormone resistant prostate cancer.

De Mulder PH, Schalken JA, Sternberg CN. De Mulder PH, et al. Among authors: sternberg cn. Ann Oncol. 2002;13 Suppl 4:95-102. doi: 10.1093/annonc/mdf645. Ann Oncol. 2002. PMID: 12401673 Free article. Review. No abstract available.

10

What's new in the treatment of advanced prostate cancer?

Sternberg CN. Sternberg CN. Eur J Cancer. 2003 Jan;39(2):136-46. doi: 10.1016/s0959-8049(02)00665-2. Eur J Cancer. 2003. PMID: 12509944 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

446 results

Search Page